reThinking eHealth Webinar Announced: Hospital Marketing in the eHealth Era
... Register for the next reThinking eHealth Webinar on July 29th at 2pm EST/ 11am pst
Birmingham, Ala. (PRWEB) July 19, 2009 -- In June of 2009, the world reached a turning point in our history. The Internet h...
Omnicell to Release Second Quarter 2009 Earnings Results on July 23
... call to
download necessary audio software.
Replay: Available starting at 2:30 p.m. PDT on July 23, 2009 through 8:59
on July 30. Dial 1-800-642-1687 within the U.S. and
1-706-645-9291 for all other locations, Conference ID # 20153924.
Z Trim Holdings Abstract Selected as 'Best of the Best' by Institute of Food Technologists
...resident of Manufacturing and Technology, Dr. Triveni Shukla, PhD., author of the abstract, will give an oral presentation in room 201AB at 11:50 a.m. pst
on Tuesday, June 9 at the annual IFT meeting.
In conformance with the requirements of the program, the IFT NPT judging subpanel recognized that ...
MessageSolution Releases SaaS Hosted Archiving Solution at Microsoft TechEd North America 2009
...; • Outlook Web Access / Domino Web Access integration available
• Offline archive access
reThinking eHealth Webinar: Will the Patient Centered Medical Home Be the Model for Universal Healthcare?
... Register for the next reThinking eHealth Webinar on April 29th at 2pm EST/ 11am pst
(PRWEB) April 19, 2009 -- What is a Patient Centered Medical Home? Why do hospital executives across North America think ha...
Follow-Up Tests of Leading Personal Care and Household Cleaning Brands Reveal Significant Improvements in Levels of Carcinogenic 1,4-dioxane
...ss conference on 1,4-dioxane in "Natural" and "Organic" Personal Care and Household Cleaning Products
WHEN: Friday, March 6, 2009, 9:00 a.m. pst
to coincide with the Natural Products Expo West
WHERE: Anaheim Hilton, 777 Convention Way, Anaheim CA, 92802, Coronado Room 4th Floor
Hope is Not a Strategy: Neither is Web 2.0 for a Hospital
...ategy hospitals need to implement to ensure success.
Join us for the next reThinking eHealth Webinar on Wednesday, January 28th at 2pm EST / 11am pst
to get details about eHealth 3.0. In addition, MEDSEEK clients and industry experts will shed light on when, where and how to use Web 2.0 tools and wh...
Omnicell to Release Fourth Quarter 2008 Earnings Results on January 29
...load necessary audio software.
Replay: Available starting at 2:30 p.m. pst
on January 29, 2009 through
8:59 p.m. pst
on February 5. Dial 1-800-642-1687 within the
U.S. and 1-706-...
Omnicell Updates 2008 Year End Guidance and Announces Company Reorganization
...ell.com . A replay of the call will be available at approximately 9:00 a.m. pst
on January 21, 2009 through 1:59 p.m. pst
on January 28. The replay access numbers are 1-800-642-1687 within the U.S....
Lumension Security Webinar Focuses on Security Mega Trends and Emerging Threats in 2009
... in a challenging business environment.
WHAT: Security Mega Trends and Emerging Threats for 2009
WHEN: January 15, 2009; 8:00 am pst
/ 11:00 am EST
WHO: Dr. Larry Ponemon, Chairman and Founder of the Ponemon Institute, Paul Henry, Security and Forensic Analyst, and Ed Brice, Senior...
PST in Medical Technology
More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
...1 & 446 ; Monday, December 8, 2008; 7:00 AM pst
& 1:45 PM PST, respectively)
Cardiac ... Abstract #335: Monday, December 8, 2008; 12:00 PM pst
International Randomized Study of Interf...H Abstract #186: Monday, December 8, 2008; 8:15 AM pst
Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
...f a Phase I Safety, Tolerability and
Pharmacokinetic Study of ANA598, a Non-Nucleoside NS5B Polymerase
Inhibitor, in Healthy Volunteers", at 1:00 p.m. pst
on Monday, November 3.
ANA598 Preclinical Data at AASLD Meeting
In addition to the results of the Phase I healthy volunteer study,
Anadys is prese...
CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
...rding to Studies Presented at American College of Rheumatology (ACR) Annual Scientific Meeting
SAN FRANCISCO, Oct. 27 /PRNewswire/ -- 5:00 AM pst
-- UCB announced
today results from several Phase III clinical trials evaluating CIMZIA(R)
(certolizumab pegol) - the only PEGylated anti-TNF (Tumor N...
Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
below, can be viewed at the AASLD website at http://www.aasld.org .
Anadys will present a late-breaker poster at a session beginning at
8:00 a.m. pst
on Monday, November 3. The poster, titled "Results of a Phase
I Safety, Tolerability and Pharmacokinetic Study of ANA598, a
Non-Nucleoside NS5B Polyme...
Clinical Experience With Peregrine's Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
...ulature Antibody, Bavituximab," is part of the Angio 2008 session on
Early Drug Development/Clinical Trial Results being held from 8:00 am to
12:00 pm pst
at the 10th Annual International Symposium on Anti-Angiogenic
Agents at the Hyatt Regency Hotel in La Jolla, CA.
About Peregrine Pharmaceuticals
Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
...al) 10 minutes prior to the start time and use the passcode
54253199. A replay of the call will be available at approximately 2:30 p.m.
EST/11:30 a.m. pst
on December 13, 2007 until December 20, 2007. To access
the replay, please dial 888-286-8010 (domestic) or 617-801-6888
(international) and use the pa...
Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
...tech management will host a conference call to discuss its
development plans for teriparatide nasal spray. The call is scheduled for 8
a.m. EST/5 a.m. pst
today, Wednesday, Nov. 7. To participate in the live
conference call, U.S. callers should dial (866) 510-0711, and international
callers should dial (...
Six-Week Investigational Study In Adults With Major Depressive
Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole
Therapy With Antidepressants
...ation at: annual
meeting of the American Psychiatric Association, San Diego,
California, Monday, May 21, 2007, 3:00 p.m. - 5:00 p.m. pst
(2) Diagnostic and Statistical Manual of Mental Disorders. Fourth ed-TR.
Psychiatry Online Web site. Avail...
Investigational Study Evaluates the Effectiveness of Aripiprazole
in Adolescents With Schizophrenia
Diego, California, Wednesday, May 23, 2007, 3:00 p.m. - 5:00 p.m. pst
Poster Session 7.
(2) Findling RL, Nyilas M, Auby P, Mallikaar... San Diego, California,
Wednesday, May 23, 2007, 3:00 p.m. - 5:00 p.m. pst
- Poster Session 7.
(3) IMS Auditrac NGPS: Abilify total monthly reta...
PST in Biological Technology
Executive Coaching Firm Mariposa Leadership, Inc. Hosts Webinar to Help Business Leaders Navigate Tumultuous Economy
...r, "Managing Fear and Uncertainty: How to Take Back Control of Your Business in this Rollercoaster Economy," takes place from 10 AM to 11 AM pst
on May 13, 2009. Sue Bethanis, CEO and founder of Mariposa Leadership, Inc., will coach participants on how to discern exactly what it is they fear, s...
Accuray Incorporated to Report Second Quarter Fiscal Year 2009 Financial Results
...call to review the results will begin at 2:00 p.m. pst
p.m. EST and will be hosted by Euan S. Thom... available beginning January 29,
2009 at 5:00 p.m. pst
/ 8:00 p.m. EST and ending on January 31, 2009. Th...rsday,
January 29, 2009 at approximately 5:00 p.m. pst
/ 8:00 p.m. EST. The replay
will remain available...
ImmunoVaccine Technologies Presents at OneMed Place Finance Forum
... CA. For more information visit www.onemedplace.com .
Dr. Randal Chase, president and CEO of ImmunoVaccine Technologies Inc., will speak at 8:45 am pst
on the development of its superior vaccine delivery system, DepoVax(TM). DepoVax(TM) is being used to develop a single-dose rapid response pandemic in...
Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma
...e to solicit additional proxies on the proposal authorizing the
reverse stock split.
The Nuvelo stockholder meeting will reconvene at 9:00 a.m. pst
23, 2009 at Nuvelo's corporate headquarters located at 201 Industrial Road,
Suite 310, San Carlos, California to consider the proposal to a...
Par Pharmaceutical to Present at the 27th Annual J.P. Morgan Healthcare Conference
...maceutical Companies, Inc. (NYSE: PRX ) will be presenting at the 27th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, at 3:00 pm pst
at the Westin St. Francis Hotel.
The audio-only live webcast will be accessible through the J.P. Morgan website at http://metameetings.com/web...
Accuray Incorporated's CEO to Speak at 27th Annual JP Morgan Healthcare Conference
...mson, Ph.D., is
scheduled to present at the 27th Annual JP Morgan Healthcare Conference in San
Francisco, on Wednesday, January 14, 2009 at 11:30 a.m. pst
(2:30 p.m. EST).
A live webcast of the presentation will be available online from the
investor relations page of the Company's Web site at htt...
Rigel to Host Conference Call to Discuss Phase 2 Study Results of R788 in Lymphoma Presented at ASH
...ll be available, in webcast and
podcast formats, at approximately 6:00 p.m. pst
on December 7, 2008 through
December 14, 2008. To access the replay, please...ation Details
Plenary session: Sunday, December 7, 2008 - 2:40 p.m. pst
Title: 3 - Fostamatinib Disodium (FosD), An Oral Inhibitor of Syk, ...
KGI Entrepreneur Program Hosts Angel Investing Educational Meeting
...wth companies in Southern California, is open to members of the public interested in becoming angel investors. The educational session begins at 3 pm pst
on the KGI campus. To attend or learn more about angel investing and TCA, send an email to TCA at InlandEmpire@techcoastangels.com " target="_new"> ...
Interleukin Genetics Reports Third Quarter 2008 Financial Results
new license agreement with OralDNA to market our pst
Genetic Test as an
assessment of risk for periodon...additional channels of its choosing.
-- Licensed pst
Genetic Test to OralDNA Labs, Inc.: In August 2008...les and distribution
agreement for its proprietary pst
genetic risk assessment test for use in
Genmab A/S: Ofatumumab Pivotal CLL Data to be Presented at ASH
...l three ofatumumab
abstracts are available on the ASH website at http://www.hematology.org .
Oral Presentation December 8 at 11:45AM pst
- Ofatumumab (HuMax-CD20),
a Novel CD20 Monoclonal Antibody, Is An Active Treatment for Patients with
CLL Refractory to Both Fludarabine and Alemtuzum...